New COVID-19 pill cut hospital, death risk by 90%


Pfizer is joining the race to bring easy to use covert nineteen medication to the U. S. market the drug maker says its experimental antiviral pill cuts rates of hospitalization and death by nearly ninety percent Pfizer plans to ask the food and drug administration and the international regulators to authorize it as soon as possible after Fizer applies the FDA could make a decision within weeks or months the FDA already is reviewing Merck's cobit nineteen pill on Thursday the United Kingdom became the first country to okay it currently all cobit nineteen treatments used in the U. S. require an IV or injection my camp in Washington

Coming up next